Dr. Dagmar Zunner, Molecular Devices (Germany) GmbH, Biberach at the Riss, Germany

Cloning and subsequently screening for biotherapeutic agents is a labour intensive and time consuming workflow. To increase the quality and efficiency of your screening and reduce labor and time requirements, Molecular Devices offers automated clone picking systems for mammalian, bacterial and yeast cells. These systems have been added to the product portfolio after the merger of Molecular Devices with its former sister company Genetix. Provided with imaging software, specific algorithms for screening are applied to ensure the picking of high quality clones. Furthermore, specific methods can be programmed and implemented to bring your manual workflow to a greater level of automation.